chr12-2053575-AAT-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_000719.7(CACNA1C):c.15_16delTA(p.Thr6fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000181 in 1,600,686 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000019 ( 0 hom. )
Consequence
CACNA1C
NM_000719.7 frameshift
NM_000719.7 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.18
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 41 pathogenic variants in the truncated region.
BS2
High AC in GnomAdExome4 at 27 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000406454.8 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000347598.9 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000399638.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.15_16delTA | p.Thr6fs | frameshift_variant | 1/46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000682544.1 | c.140-61647_140-61646delTA | intron_variant | ENSP00000507184.1 | ||||||
CACNA1C | ENST00000683824.1 | c.140-61647_140-61646delTA | intron_variant | ENSP00000507867.1 | ||||||
CACNA1C | ENST00000682462.1 | c.140-61647_140-61646delTA | intron_variant | ENSP00000507105.1 | ||||||
CACNA1C | ENST00000683781.1 | c.140-61647_140-61646delTA | intron_variant | ENSP00000507434.1 | ||||||
CACNA1C | ENST00000683840.1 | c.140-61647_140-61646delTA | intron_variant | ENSP00000507612.1 | ||||||
CACNA1C | ENST00000683956.1 | c.140-61647_140-61646delTA | intron_variant | ENSP00000506882.1 | ||||||
CACNA1C | ENST00000480911.6 | n.15_16delTA | non_coding_transcript_exon_variant | 1/27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152036Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
152036
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000883 AC: 2AN: 226604Hom.: 0 AF XY: 0.00000815 AC XY: 1AN XY: 122720
GnomAD3 exomes
AF:
AC:
2
AN:
226604
Hom.:
AF XY:
AC XY:
1
AN XY:
122720
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000186 AC: 27AN: 1448650Hom.: 0 AF XY: 0.0000139 AC XY: 10AN XY: 719244
GnomAD4 exome
AF:
AC:
27
AN:
1448650
Hom.:
AF XY:
AC XY:
10
AN XY:
719244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152036Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74274
GnomAD4 genome
AF:
AC:
2
AN:
152036
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
CACNA1C-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 27, 2024 | The CACNA1C c.15_16delTA variant is predicted to result in a frameshift and premature protein termination (p.Thr6Glufs*35). This variant was reported in an individual with atrial fibrillation (Yoneda et al 2021. PubMed ID: 34495297). This variant is reported in 0.0026% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in CACNA1C are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 26, 2024 | Identified in an individual from a cohort with early onset atrial fibrillation in published literature (PMID: 34495297); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34495297) - |
Timothy syndrome;C2678478:Brugada syndrome 3;CN260585:Long qt syndrome 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 11, 2021 | - - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 190711). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. This variant is present in population databases (rs786205782, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Thr6Glufs*35) in the CACNA1C gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CACNA1C cause disease. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2022 | The c.15_16delTA variant, located in coding exon 1 of the CACNA1C gene, results from a deletion of two nucleotides at nucleotide positions 15 to 16, causing a translational frameshift with a predicted alternate stop codon (p.T6Efs*35). The predicted stop codon occurs in the 5’ end of theCACNA1C gene. Premature termination codons in the 5’ end of a gene have been reported to escape nonsense-mediated mRNAdecay and/or lead to re-initiation (Rivas et al. Science. 2015 May 8;348(6235):666-9; Lindeboom et al. Nat Genet. 2016 Oct;48(10):1112-8; Rhee et al. Sci Rep. 2017 May 10;7(1):1653). The exact functional effect of this alteration is unknown. According to data from gnomAD, the frequency for this variant is above the maximum credible frequency for a cardiac disease-causing variant in this gene based on internally established thresholds (Karczewski et al. Nature. 2020 May;581(7809):434-443; Whiffin et al. Genet Med. 2017 10;19:1151-1158). Based on the supporting evidence, the association of this alteration with CACNA1C-related neurodevelopmental disorder is unknown; however, the association with CACNA1C-related long QT syndrome or Timothy syndrome is unlikely. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at